Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
28,863,350
-
Share change
-
+995,861
-
Total reported value
-
$1,308,782,704
-
Put/Call ratio
-
44%
-
Price per share
-
$45.36
-
Number of holders
-
137
-
Value change
-
+$55,156,732
-
Number of buys
-
80
-
Number of sells
-
63
Institutional Holders of CLOVIS ONCOLOGY INC - COM (CLVSQ) as of Q3 2014
As of 30 Sep 2014,
CLOVIS ONCOLOGY INC - COM (CLVSQ) was held by
137 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
28,863,350 shares.
The largest 10 holders included
FMR LLC, NEA Management Company, LLC, OPPENHEIMER FUNDS INC, Palo Alto Investors, LLC, ADAGE CAPITAL PARTNERS GP LLC, VANGUARD GROUP INC, Partner Fund Management, L.P., PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Fund Advisors, and CLIFTON PARK CAPITAL MANAGEMENT, LLC.
This page lists
137
institutional shareholders reporting positions in this security
for the Q3 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.